Australia
· Delayed Price · Currency is AUD Firebrick Pharma Statistics
Total Valuation
ASX:FRE has a market cap or net worth of AUD 15.27 million. The enterprise value is 14.36 million.
| Market Cap | 15.27M |
| Enterprise Value | 14.36M |
Important Dates
The next estimated earnings date is Wednesday, May 21, 2025.
| Earnings Date | May 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:FRE has 224.58 million shares outstanding. The number of shares has increased by 10.34% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 224.58M |
| Shares Change (YoY) | +10.34% |
| Shares Change (QoQ) | +11.01% |
| Owned by Insiders (%) | 33.62% |
| Owned by Institutions (%) | n/a |
| Float | 104.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.50 |
| PB Ratio | 10.20 |
| P/TBV Ratio | 10.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.33 |
| EV / Sales | 12.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.20 |
Financial Position
The company has a current ratio of 4.43
| Current Ratio | 4.43 |
| Quick Ratio | 3.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,588.62 |
Financial Efficiency
Return on equity (ROE) is -111.71% and return on invested capital (ROIC) is -64.79%.
| Return on Equity (ROE) | -111.71% |
| Return on Assets (ROA) | -52.89% |
| Return on Invested Capital (ROIC) | -64.79% |
| Return on Capital Employed (ROCE) | -106.88% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.60 |
| Inventory Turnover | 0.34 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.68% in the last 52 weeks. The beta is 1.63, so ASX:FRE's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | +9.68% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 29.26 |
| Average Volume (20 Days) | 66,773 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:FRE had revenue of AUD 1.13 million and -1.72 million in losses. Loss per share was -0.01.
| Revenue | 1.13M |
| Gross Profit | 1.04M |
| Operating Income | -1.60M |
| Pretax Income | -1.72M |
| Net Income | -1.72M |
| EBITDA | -1.59M |
| EBIT | -1.60M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 911,201 in cash and n/a in debt, giving a net cash position of 911,201 or 0.00 per share.
| Cash & Cash Equivalents | 911,201 |
| Total Debt | n/a |
| Net Cash | 911,201 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.50M |
| Book Value Per Share | 0.01 |
| Working Capital | 1.16M |
Cash Flow
In the last 12 months, operating cash flow was -1.93 million and capital expenditures -66,488, giving a free cash flow of -1.99 million.
| Operating Cash Flow | -1.93M |
| Capital Expenditures | -66,488 |
| Free Cash Flow | -1.99M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 91.68%, with operating and profit margins of -141.41% and -152.38%.
| Gross Margin | 91.68% |
| Operating Margin | -141.41% |
| Pretax Margin | -152.38% |
| Profit Margin | -152.38% |
| EBITDA Margin | -140.83% |
| EBIT Margin | -141.41% |
| FCF Margin | n/a |
Dividends & Yields
ASX:FRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.34% |
| Shareholder Yield | -10.34% |
| Earnings Yield | -11.29% |
| FCF Yield | -13.06% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:FRE has an Altman Z-Score of 3.92.
| Altman Z-Score | 3.92 |
| Piotroski F-Score | n/a |